Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease

Anjie Suzanne I, D'Haens Geert R., Baert Filip, Bossuyt Peter, Hoentjen Frank, Clasquin Esme, Molnár Tamás, Lowenberg Mark, Vermeire Severine, Panetta J. Carl, Dervieux Thierry
2026

Vedolizumab in early and late Crohn's disease (LOVE-CD) a phase 4 open-label cohort study /

D'Haens Geert R, Löwenberg Mark, Baert Filip, Bossuyt Peter, Molnár Tamás, Hoentjen Frank, Clasquin Esmé, Gecse Krisztina B, Hulshoff Melanie S, De Hertogh Gert, Lenfant Matthias, Oldenburg Lotte, Vermeire Séverine
2026

Building a Robust Investigator-Initiated Platform The I-CARE Experience /

Kirchgesner Julien, Beaugerie Laurent, Baumann Cédric, Baert Filip, Rahier Jean-François, Bergemalm Daniel, Cañete Fiorella, Caron Bénédicte, Cossignani Marta, Dias Sandra, Farkas Klaudia, Girod Parker, Goren Idan, Holvoet Tom, Krasz Susanne, Kumar Aditi, Rimmer Peter, Sheridan Juliette, Thut Jessica, Uzzan Mathieu, Viazis Nikos, Weimers Petra, Zagórowicz Edyta, Buisson Anne, Avedano Luisa, Rousseau Helene, Peyrin-Biroulet Laurent, Sebastian Shaji, Molnár Tamás, Szepes Zoltán, Nagy Ferenc, Bor Renáta, Bálint Anita, Fábián Anna, Rutka Mariann, Milassin Ágnes, et al
2026